These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 28551661

  • 1. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.
    Xia L, Hu G, Guzzo TJ.
    Anticancer Res; 2017 Jun; 37(6):3175-3181. PubMed ID: 28551661
    [Abstract] [Full Text] [Related]

  • 2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 3. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, Gregg JR, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE.
    Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
    [Abstract] [Full Text] [Related]

  • 4. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F, de Martino M, Leitner CV, Moschini M, Shariat SF, Klatte T.
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [Abstract] [Full Text] [Related]

  • 5. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [Abstract] [Full Text] [Related]

  • 6. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM, Mehra R, Tiemeny P, Wolf JS, Wu S, Sangale Z, Brawer M, Stone S, Wu CL, Feldman AS.
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [Abstract] [Full Text] [Related]

  • 7. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 8. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC.
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP, Lohse CM, Zaid HB, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [Abstract] [Full Text] [Related]

  • 10. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [Abstract] [Full Text] [Related]

  • 11. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boleti E, Sahdev A, O'Brien T, Berney D, Beltran L, Nathan P, Haanen J, Bex A.
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S, Han Y, Park H, Chung YS, Ahn H, Kim CS, Cho YP, Kwon TW.
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [Abstract] [Full Text] [Related]

  • 15. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience.
    Ciancio G, Manoharan M, Katkoori D, De Los Santos R, Soloway MS.
    Eur Urol; 2010 Apr; 57(4):667-72. PubMed ID: 19560258
    [Abstract] [Full Text] [Related]

  • 16. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
    Ko K, Park YH, Lee JW, Ku JH, Kwak C, Kim HH.
    BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
    [Abstract] [Full Text] [Related]

  • 17. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, Dahl DM, Wu S, Blute ML, Huang Y, Wu CL.
    Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
    [Abstract] [Full Text] [Related]

  • 18. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
    Yang H, Yin K, Wang Y, Xia M, Zhang R, Wang W, Chen J, Wang C, Shuang W.
    J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of prognostic nutritional index in renal cell carcinomas.
    Tang Y, Liang J, Liu Z, Zhang R, Zou Z, Wu K, Lu Y, Wei X.
    Medicine (Baltimore); 2021 Mar 12; 100(10):e25127. PubMed ID: 33725913
    [Abstract] [Full Text] [Related]

  • 20. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    J Urol; 2009 Feb 12; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.